News

CooperVision’s Dr. Arthur Bradley Recognized as a 2024 Wavefront Congress Luminary

Dr. Bradley is lauded for his distinguished career and ongoing contributions to myopia management and optometry mentorship.

Read More

Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone

Vivity is the most implanted extended depth of focus (EDOF) intraocular lens (IOL) globally

Read More

Ted Lasso Director Takes on New Specsavers ‘Should’ve Gone to Specsavers’ Campaign ‘Airport’

Specsavers Canada launched its new 'Should've Gone to Specsavers' campaign with a spot called 'Airport'.

Read More

Opto-Réseau Expands with ‘C’est la vue’ Clinic in Ahuntsic-Cartierville

Founded in 1989, 'C'est la vue' has built a strong reputation as a reference in optics in the Ahuntsic-Cartierville neighborhood.

Read More

SS24 VANGUARD Collection: The Epitome of Sophistication and Sustainability

The new GIGI STUDIOS SS24 VANGUARD collection comprises lighter, hand-crafted models of reduced weight thanks to thinner acetates and carefully designed inner bezels.

Read More

Eschenbach Optik of America Introduces its New Asensys® Absorptive Filters

Eschenbach introduces its new Asensys® filters, a line of contrast-enhancing eyewear designed to either fit over patients’ prescription glasses or be worn alone and provide all-round protection against the sun and unpleasant glare.

Read More

CooperVision GSLS 2024 Scientific Program Advances Myopia Control & Irregular Cornea Care

MiSight® 1 day Efficacy for Fast/Slow Progressors, Pediatric Prescribing Trends, and Scleral Lens Use for Dry Eye Among Research Papers and Posters Highlights

Read More

Latest CORE Publication Offers Specialty Contact Lens and Myopia Management Insights for Practitioners

Advancements in and increased fitting of scleral and corneo-scleral lenses, plus resurgent interest surrounding orthokeratology for managing myopia control, sets the stage for Issue 76 of Contact Lens Update.

Read More

Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial

Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease.

Read More

Dynamic & Comprehensive VisionEd Conference Program Announced for VEE 2024

The Vision Council and RX, co-organizers of Vision Expo, bring compelling accredited continuing education offerings to the industry at Vision Expo East 2024.

Read More
1 29 30 31 32 33 406